Detailed Information on Publication Record
2018
Structural basis for antibiotic resistance mediated by the Bacillus subtilis ABCF ATPase VmlR
CROWE-MCAULIFFE, C., M. GRAF, P. HUTER, H. TAKADA, M. ABDELSHAHID et. al.Basic information
Original name
Structural basis for antibiotic resistance mediated by the Bacillus subtilis ABCF ATPase VmlR
Authors
CROWE-MCAULIFFE, C. (276 Germany), M. GRAF (276 Germany), P. HUTER (276 Germany), H. TAKADA (752 Sweden), M. ABDELSHAHID (276 Germany), Jiří NOVÁČEK (203 Czech Republic, guarantor, belonging to the institution), V. MURINA (752 Sweden), G.C. ATKINSON (752 Sweden), V. HAURYLIUK (752 Sweden) and D.N. WILSON (276 Germany)
Edition
Proceedings of the National Academy of Sciences of the United States of America, WASHINGTON, NATL ACAD SCIENCES, 2018, 0027-8424
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 9.580
RIV identification code
RIV/00216224:14740/18:00106666
Organization unit
Central European Institute of Technology
UT WoS
000443555000057
Keywords in English
ABC ATPase; cryo-EM; ribosome; antibiotic resistance; VmlR
Tags
International impact, Reviewed
Změněno: 19/3/2019 16:25, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Many Gram-positive pathogenic bacteria employ ribosomal protection proteins (RPPs) to confer resistance to clinically important antibiotics. In Bacillus subtilis, the RPP VmlR confers resistance to lincomycin (Lnc) and the streptogramin A (SA) antibiotic virginiamycin M (VgM). VmlR is an ATP-binding cassette (ABC) protein of the F type, which, like other antibiotic resistance (ARE) ABCF proteins, is thought to bind to antibiotic-stalled ribosomes and promote dissociation of the drug from its binding site. To investigate the molecular mechanism by which VmlR confers antibiotic resistance, we have determined a cryo-electron microscopy (cryo-EM) structure of an ATPase-deficient B. subtilis VmlR-EQ(2) mutant in complex with a B. subtilis ErmDL-stalled ribosomal complex (SRC). The structure reveals that VmlR binds within the E site of the ribosome, with the antibiotic resistance domain (ARD) reaching into the peptidyltransferase center (PTC) of the ribosome and a C-terminal extension (CTE) making contact with the small subunit (SSU). To access the PTC, VmlR induces a conformational change in the P-site tRNA, shifting the acceptor arm out of the PTC and relocating the CCA end of the P-site tRNA toward the A site. Together with microbiological analyses, our study indicates that VmlR allosterically dissociates the drug from its ribosomal binding site and exhibits specificity to dislodge VgM, Lnc, and the pleuromutilin tiamulin (Tia), but not chloramphenicol (Cam), linezolid (Lnz), nor the macrolide erythromycin (Ery).
Links
LM2015043, research and development project |
|